Can parathyroid hormone be used as a biomarker for heart failure?

Landry CS, Ruppe MD, Grubbs EG (2011) Vitamin D receptors and parathyroid glands. Endocr Pract 17(suppl 1):63–68 DeLuca HF (2004) Overview of general physiologic features and functions of vitamin D. Am J Clin Nutr 80(6 suppl):1689S–1696S Witham MD, Vitamin D (2011) in chronic heart failure. Curr Heart Fail Rep 8(2):123–130 Haussler MR, McCain TA (1977) Basic and clinical concepts related to vitamin D metabolism and action (second of two parts). N Engl J Med 297(19):1041–1050 Bassler T, Wong ET, Brynes RK (1993) Osteitis fibrosa cystica simulating metastatic tumor. An almost-forgotten relationship. Am J Clin Pathol 100(6):697–700 Vigorita VJ, Einhorn TA, Phelps KR (1987) Microscopic bone pathology in two cases of surgically treated secondary hyperparathyroidism. Report of a distinct skeletal lesion. Am J Surg Pathol 11(3):205–209 Bjorkman M, Sorva A, Tilvis R (2009) Responses of parathyroid hormone to vitamin D supplementation: a systematic review of clinical trials. Arch Gerontol Geriatr 48(2):160–166 Silver J, Levi R (2005) Regulation of PTH synthesis and secretion relevant to the management of secondary hyperparathyroidism in chronic kidney disease. Kidney Int Suppl 95:S8–S12 Ross H, Howlett J, Arnold JM et al (2006) Treating the right patient at the right time: access to heart failure care. Can J Cardiol 22(9):749–754 Johansen H, Strauss B, Arnold JM, Moe G, Liu P (2003) On the rise: the current and projected future burden of congestive heart failure hospitalization in Canada. Can J Cardiol 19(4):430–435 Braunwald E (2008) Biomarkers in heart failure. N Engl J Med 358(20):2148–2159 Arnold JM, Liu P, Demers C et al (2006) Canadian cardiovascular society consensus conference recommendations on heart failure 2006: diagnosis and management. Can J Cardiol 22(1):23–45 Kamalov G, Bhattacharya SK, Weber KT (2010) Congestive heart failure: where homeostasis begets dyshomeostasis. J Cardiovasc Pharmacol 56(3):320–328 McAlister FA, Ezekowitz J, Tonelli M, Armstrong PW (2004) Renal insufficiency and heart failure: prognostic and therapeutic implications from a prospective cohort study. Circulation 109(8):1004–1009 Weber KT (2001) Aldosterone in congestive heart failure. N Engl J Med 345(23):1689–1697 Goulding A, Campbell D (1983) Dietary NaCl loads promote calciuria and bone loss in adult oophorectomized rats consuming a low calcium diet. J Nutr 113(7):1409–1414 Galla JH (2000) Metabolic alkalosis. J Am Soc Nephrol 11(2):369–375 Isakova T, Anderson CA, Leonard MB et al (2011) Diuretics, calciuria and secondary hyperparathyroidism in the chronic renal insufficiency cohort. Nephrol Dial Transplant 26(4):1258–1265 Fujita T, Palmieri GM (2000) Calcium paradox disease: calcium deficiency prompting secondary hyperparathyroidism and cellular calcium overload. J Bone Miner Metab 18(3):109–125 Tian J, Smogorzewski M, Kedes L, Massry SG (1993) Parathyroid hormone-parathyroid hormone related protein receptor messenger RNA is present in many tissues besides the kidney. Am J Nephrol 13(3):210–213 Grey A, Mitnick MA, Shapses S, Ellison A, Gundberg C, Insogna K (1996) Circulating levels of interleukin-6 and tumor necrosis factor-alpha are elevated in primary hyperparathyroidism and correlate with markers of bone resorption–a clinical research center study. J Clin Endocrinol Metab 81(10):3450–3454 Schluter KD, Weber M, Piper HM (1995) Parathyroid hormone induces protein kinase C but not adenylate cyclase in adult cardiomyocytes and regulates cyclic AMP levels via protein kinase C-dependent phosphodiesterase activity. Biochem J 310(Pt 2):439–444 Shimoyama M, Ogino K, Furuse Y et al (2001) Signaling pathway and chronotropic action of parathyroid hormone in isolated perfused rat heart. J Cardiovasc Pharmacol 38(4):491–499 Hara M, Liu YM, Zhen L et al (1997) Positive chronotropic actions of parathyroid hormone and parathyroid hormone-related peptide are associated with increases in the current, I(f), and the slope of the pacemaker potential. Circulation 96(10):3704–3709 Kamycheva E, Sundsfjord J, Jorde R (2004) Serum parathyroid hormone levels predict coronary heart disease: the Tromso study. Eur J Cardiovasc Prev Rehabil 11(1):69–74 Schmitz F, Ewering S, Zerres K, Klomfass S, Hoffmann R, Ortlepp JR (2009) Parathyroid hormone gene variant and calcific aortic stenosis. J Heart Valve Dis 18(3):262–267 Carlstedt F, Lind L, Wide L et al (1997) Serum levels of parathyroid hormone are related to the mortality and severity of illness in patients in the emergency department. Eur J Clin Invest 27(12):977–981 Pilz S, Tomaschitz A, Ritz E, Pieber TR (2009) Vitamin D status and arterial hypertension: a systematic review. Nat Rev Cardiol 6(10):621–630 McGreevy C, Williams D (2011) New insights about vitamin D and cardiovascular disease: a narrative review. Ann Intern Med 155(12):820–826 Kestenbaum B, Katz R, de Boer I et al (2011) Vitamin D, parathyroid hormone, and cardiovascular events among older adults. J Am Coll Cardiol 58(14):1433–1441 Altay H, Zorlu A, Binici S et al. (2012) Relation of serum parathyroid hormone level to severity of heart failure. Am J Cardiol 109(2):252–256 Loncar G, Bozic B, Dimkovic S et al (2011) Association of increased parathyroid hormone with neuroendocrine activation and endothelial dysfunction in elderly men with heart failure. J Endocrinol Invest 34(3):e78–e85 Garakyaraghi M, Kerdegari M, Siavash M (2010) Calcium and vitamin D status in heart failure patients in Isfahan, Iran. Biol Trace Elem Res 135(1–3):67–73 Mancini DM, Eisen H, Kussmaul W, Mull R, Edmunds LH Jr, Wilson JR (1991) Value of peak exercise oxygen consumption for optimal timing of cardiac transplantation in ambulatory patients with heart failure. Circulation 83(3):778–786 Agapitou V, Dimopoulos S, Mpouchla A et al (2011) Serum intact parathyroid hormone levels independently predict exercise capacity in stable heart failure patients. Int J Cardiol 146(3):462–464 Hagstrom E, Ingelsson E, Sundstrom J et al (2010) Plasma parathyroid hormone and risk of congestive heart failure in the community. Eur J Heart Fail 12(11):1186–1192 Sugimoto T, Tanigawa T, Onishi K et al (2009) Serum intact parathyroid hormone levels predict hospitalisation for heart failure. Heart 95(5):395–398 Schierbeck LL, Jensen TS, Bang U, Jensen G, Kober L, Jensen JE (2011) Parathyroid hormone and vitamin D–markers for cardiovascular and all cause mortality in heart failure. Eur J Heart Fail 13(6):626–632 Miller WL, Hartman KA, Burritt MF et al (2007) Serial biomarker measurements in ambulatory patients with chronic heart failure: the importance of change over time. Circulation 116(3):249–257 Aspromonte N, Valle R, Peacock WF, Vanderheyden M, Maisel A (2008) Inpatient monitoring and prognostic importance of B-type natriuretic peptide. Congest Heart Fail 14(4 suppl 1):30–34 Morrow DA, de Lemos JA (2007) Benchmarks for the assessment of novel cardiovascular biomarkers. Circulation 115(8):949–952 Tang WH, Francis GS, Morrow DA et al (2007) National academy of clinical biochemistry laboratory medicine practice guidelines: clinical utilization of cardiac biomarker testing in heart failure. Circulation 116(5):e99–e109